Healthcare & Life Sciences
TrophoSYS
Germany
aliveseed
seed
Stage
1
Investors
About
TrophoSYS develops innovative therapies for neurodegenerative diseases, focusing on active ingredients that protect nerve cells and promote their regeneration. Their lead candidate is a small molecule showing promise in preclinical models for diseases like Alzheimer's and Parkinson's.
Explore TrophoSYS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.